SCHEMBL2566022

SCHEMBL2566022

CC(=C(C#N)C(=O)O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
MAPT P10636 4/20 0.51
RAB9A P51151 3/20 0.51
LMNA P02545 2/20 0.51
MAPK1 P28482 2/20 0.51
XBP1 P17861 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
CES2 O00748 3/20 0.43
CES1 P23141 3/20 0.43
DHODH Q02127 1/20 0.42
CYP19A1 P11511 2/20 0.41
KMT2A Q03164 3/20 0.40
HPGD P15428 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
DAO P14920 1/20 0.39
TSHR P16473 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
ESR1 P03372 1/20 0.38
NPC1 O15118 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3289274 1.00 ALDH1A1 (0.51) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL2566020 1.00 ALDH1A1 (0.51) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL11640891 0.89 SMN1; SMN2 (0.53) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL11640894 0.89 SMN1; SMN2 (0.53) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL28420371 0.88 ALDH1A1 (0.51) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL28892760 0.86 ALDH1A1 (0.64) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL29119462 0.86 TSHR (0.46) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL16534386 0.85 SLC16A3 (0.43) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL16534389 0.85 SLC16A3 (0.43) ALDH1A1MAPTRAB9ALMNAMAPK1
SCHEMBL9447417 0.85 ALDH1A1 (0.47) ALDH1A1MAPTRAB9ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210324344-A1 ENONE REDUCTASES INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2021-10-21 US disclosed
US-10995321-B2 Enone reductases CODEXIS, INC. (US) 2021-05-04 US disclosed
US-20200040311-A1 ENONE REDUCTASES INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2020-02-06 US disclosed
US-20180312815-A1 ENONE REDUCTASES INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2018-11-01 US disclosed
CN-108484849-A A kind of block type ionomer antistatic agent and preparation method thereof 湖南辰砾新材料有限公司 2018-09-04 CN disclosed
US-10035988-B2 Enone reductases CODEXIS, INC. (US) 2018-07-31 US disclosed
US-20170175087-A1 ENONE REDUCTASES INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2017-06-22 US disclosed
US-9617568-B2 Enone reductases CODEXIS, INC. (US) 2017-04-11 US disclosed
US-20160273007-A1 ENONE REDUCTASES INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2016-09-22 US disclosed
US-9388438-B2 Enone reductases CODEXIS, INC. (US) 2016-07-12 US disclosed
US-7718096-B2 Stabilized electrochromic media CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-18 US disclosed
US-7595011-B2 One or more solvents, one or more materials which are functional elements of electrochromic devices, one or more ultraviolet light absorbers selected from hydroxyphenylbenzotriazoles and tris-aryl-s-triazines, and one or more NH or N-alkyl hindered amine light stabilizers; discoloration inhibition CIBA SPECIALTY CHEMICALS CORPORATION (US) 2009-09-29 US disclosed
EP-1896550-A1 STABILIZED ELECTROCHROMIC MEDIA Ciba Specialty Chemicals Holding Inc. (CH) 2008-03-12 EP disclosed
EP-1789842-A1 STABILIZED ELECTROCHROMIC MEDIA CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-05-30 EP disclosed
WO-2007003508-A1 STABILIZED ELECTROCHROMIC MEDIA CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-01-11 WO disclosed
US-20070002423-A1 Stabilized electrochromic media CIBA SPECIALTY CHEMICALS CORP. 2007-01-04 US disclosed
WO-2006005691-A1 STABILIZED ELECTROCHROMIC MEDIA CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-01-19 WO disclosed
US-20060007519-A1 Stabilized electrochromic media CIBA SPECIALTY CHEMICALS CORP. 2006-01-12 US disclosed
US-6365311-B1 THERMAL STABILITY; LOW COLOR; ABSENCE OF ENVIRONMENTALLY UNDESIRABLE TOXIC METALS; POLYETHERIFIED BISPHENOL A FUMARATE BINDER; POLYSILOXANE COATED STRONTIUM FERRITE CARRIER EASTMAN KODAK COMPANY 2002-04-02 US disclosed
US-5266718-A Antidiabetic agents ADIR ET COMPAGNIE (FR) 1993-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312815-A1 ENONE REDUCTASES ENO1, DCXR, RRM2B ALDH1A1 1267/4885MAPT 4492/4885RAB9A 3233/4885
US-10995321-B2 Enone reductases ENO1, DCXR, RRM2B ALDH1A1 1267/4885MAPT 4492/4885RAB9A 3233/4885
US-20200040311-A1 ENONE REDUCTASES ENO1, DCXR, RRM2B ALDH1A1 1267/4885MAPT 4492/4885RAB9A 3233/4885
US-20210324344-A1 ENONE REDUCTASES ENO1, DCXR, RRM2B ALDH1A1 1267/4885MAPT 4492/4885RAB9A 3233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.